investordatabase.org

4BIO Partners LLP

4biocapital.com Direct investor

4BIO Capital is a London-based venture capital firm focused on investing in early-stage companies developing advanced therapies, including cell and gene therapy, RNA-based therapy, targeted therapies, and microbiome treatments.

4BIO Partners LLP is a venture capital firm headquartered in London, United Kingdom. It invests directly in companies, from seed to Series A, in advanced therapies, cell and gene therapy, RNA-based therapy and targeted therapies.

“4BIO's objective is to invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients.”

4BIO Partners LLP, own website
Layer
Direct investor
Type
Venture capital
Stage
SeedSeries A
Headquarters
London, United Kingdom
Sectors
advanced therapies, cell and gene therapy, RNA-based therapy, targeted therapies, microbiome

Team, as 4BIO Partners LLP publishes it

  • Philippe Fauchet OBE Venture Partner, Japan
  • Vasily Fedorin PhD Chief Operating Officer
  • Natalie Johnston PhD Investment Principal
  • Andrew Kozlov MBA Managing Partner
  • Dima Kuzmin PhD Managing Partner
  • Therese Liechtenstein PhD Partner
  • Tetsu Maruyama PhD Venture Partner
  • Edward McGill FCA Financial Controller
  • Alexander McKenna PhD Investment Associate
  • Brian McVeigh MBA Venture Partner, USA
  • Kieran Mudryy LLB Partner
  • Shikin Gani Executive Assistant

Names and roles exactly as listed on 4biocapital.com. Nothing else about these people is recorded.

Co-invests most often with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 2 co-investors found.

Where this comes from

Every fact above was read from a page 4BIO Partners LLP publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 3213 · added 2026-09-03 · link last verified 2026-09-06 · confidence high

Similar investors

Listed under